Disc Medicine
Stock Forecast, Prediction & Price Target
Disc Medicine Financial Estimates
Disc Medicine Revenue Estimates
Disc Medicine EBITDA Estimates
Disc Medicine Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $8.37M Low: $8.37M High: $8.37M avg. 0% | Avg: $3.34M Low: $3.34M High: $3.34M avg. -60.11% | Avg: $28.52M Low: $28.52M High: $28.52M avg. 754.05% | Avg: $145.73M Low: $145.73M High: $145.73M avg. 410.88% |
Net Income
% change YoY
| $-41.00M N/A | $-46.09M -12.40% | $-76.42M -65.82% | Avg: $-143.83M Low: $-120.72M High: $-101.53M avg. -88.19% | Avg: $-180.38M Low: $-154.64M High: $-112.24M avg. -25.40% | Avg: $-144.11M Low: $-144.11M High: $-144.11M avg. 20.10% | Avg: $-75.33M Low: $-75.33M High: $-75.33M avg. 47.72% |
EBITDA
% change YoY
| $-25.85M N/A | $-47.47M -83.64% | $-91.02M -91.73% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$12.8 N/A | -$44.34 -246.40% | -$3.43 92.26% | Avg: -$5.11 Low: -$5.41 High: -$4.55 avg. -49.02% | Avg: -$6.07 Low: -$6.93 High: -$5.03 avg. -18.82% | Avg: -$6.46 Low: -$6.46 High: -$6.46 avg. -6.32% | Avg: -$3.38 Low: -$3.38 High: -$3.38 avg. 47.72% |
Operating Expenses
% change YoY
| $30.93M N/A | $47.47M 53.47% | $91.12M 91.94% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Disc Medicine stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -11.44% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -120.72M, average is -143.83M and high is -101.53M.
What is Disc Medicine stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 276.20% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $8.37M, average is $8.37M and high is $8.37M.
What is Disc Medicine stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -6.61% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$5.41, average is -$5.11 and high is $-4.55.
What is the best performing analyst?
In the last twelve months analysts have been covering Disc Medicine stock. The most successful analyst is Greg Harrison.